The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
Ethyl 3-(2-chlorophenyl)-5,7-dimethyl-2-(((methylcarbamoyl)oxy)methyl)-4-oxo-3,4-dihydroquinazoline-6-carboxylate ID: ALA5290485
Max Phase: Preclinical
Molecular Formula: C22H22ClN3O5
Molecular Weight: 443.89
Associated Items:
Names and Identifiers Canonical SMILES: CCOC(=O)c1c(C)cc2nc(COC(=O)NC)n(-c3ccccc3Cl)c(=O)c2c1C
Standard InChI: InChI=1S/C22H22ClN3O5/c1-5-30-21(28)18-12(2)10-15-19(13(18)3)20(27)26(16-9-7-6-8-14(16)23)17(25-15)11-31-22(29)24-4/h6-10H,5,11H2,1-4H3,(H,24,29)
Standard InChI Key: NUVXJFLCRWIOHW-UHFFFAOYSA-N
Molfile:
RDKit 2D
31 33 0 0 0 0 0 0 0 0999 V2000
-2.1335 0.2045 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.1335 -0.6204 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.4201 -1.0267 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.7131 -0.6168 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.7131 0.2049 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.4219 0.6150 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.4219 1.4367 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.0034 0.6140 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.7102 0.2033 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.7102 -0.6142 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0016 -1.0291 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.4219 -1.0251 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1334 -0.6142 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.8451 -1.0251 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5567 -0.6142 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.2683 -1.0251 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8451 -1.8467 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.4203 0.6141 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1347 0.2015 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8435 0.6162 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8435 1.4338 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1302 1.8448 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.4203 1.4358 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.7086 1.8467 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
-0.0034 1.4357 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-2.8451 -1.0313 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.8451 0.6153 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.5567 0.2045 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-3.5567 -0.6171 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.2683 -1.0280 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.8451 1.4370 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 2 0
3 4 1 0
4 5 2 0
5 6 1 0
6 1 2 0
6 7 1 0
5 8 1 0
9 8 1 0
10 9 1 0
11 10 2 0
4 11 1 0
10 12 1 0
12 13 1 0
13 14 1 0
14 15 1 0
15 16 1 0
14 17 2 0
18 9 1 0
18 19 1 0
19 20 2 0
20 21 1 0
21 22 2 0
22 23 1 0
23 18 2 0
23 24 1 0
8 25 2 0
2 26 1 0
1 27 1 0
27 28 1 0
28 29 1 0
29 30 1 0
27 31 2 0
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Topical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 443.89Molecular Weight (Monoisotopic): 443.1248AlogP: 3.69#Rotatable Bonds: 5Polar Surface Area: 99.52Molecular Species: NEUTRALHBA: 7HBD: 1#RO5 Violations: ┄HBA (Lipinski): 8HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: ┄CX LogP: 4.16CX LogD: 4.16Aromatic Rings: 3Heavy Atoms: 31QED Weighted: 0.60Np Likeness Score: -1.00
References 1. Alagarsamy V, Chitra K, Saravanan G, Solomon VR, Sulthana MT, Narendhar B.. (2018) An overview of quinazolines: Pharmacological significance and recent developments., 151 [PMID:29656203 ] [10.1016/j.ejmech.2018.03.076 ]